Oncotarget: enhancing research in Cancer Management

Oncotarget is a weekly multidisciplinary traditional free-access medical journal. Founded in 2010, the journal is published by Impact Journals, with a publication one every week and the possibility of an individual book under demand. The editors in chief of the journal are Mikhail Blagosklonny and Andrei V. Gudkov, formerly of Roswell Park Cancer Institute.Although a multidisciplinary journal, Oncotarget majors mostly on oncological solutions to cancer prevention, management, and treatment. Oncology posts a three tiered approach to cancer control. The first part of the approach involves treatment, where individuals are called upon to take extensive measures to avoid factors that may end with them getting cancer such as avoiding the use of cigarettes and alcohol.

The second step involves early diagnosis where individuals are encouraged to take regular health screenings to ensure that the disease is caught in its infancy should one have cancer. People are also invited to remain vigilant and stay aware of the signs and symptoms of cancer, so that they may seek medical attention in the earliest stages of the disease when it is easier to manage and put under control. Finally, this cancer treatment method proposes a multimodal treatment method once the illness has been diagnosed, taking many different measures collaboratively to manage and control disease and avoid heightened mortality rates associated with cancer.

The journal’s mission is to make medical and scientific research quickly and widely available in the quickest manner possible. It hopes to bridge the gap between specialties and disciplines in the different fields of scientific study in the sharing and access of information and data. Exceptional discoveries can be shared widely and quickly through the journal and an extensive peer review process enhanced through its robust peer review policy. Different fields of biomedical science are linked through the journal and the applications of basic and clinical science increased in the prevention and treatment of disease. More importantly, however, Oncotarget provides an avenue where researchers and scientists can publish their work and have it peer reviewed, receiving positive criticism and meaningful discussions in different areas of scientific research and medicine.

 

Comments are closed.